SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-325511
Filing Date
2018-11-13
Accepted
2018-11-13 16:20:59
Documents
67
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d624778d10q.htm 10-Q 814216
2 EX-31.1 d624778dex311.htm EX-31.1 10947
3 EX-31.2 d624778dex312.htm EX-31.2 10949
4 EX-32.1 d624778dex321.htm EX-32.1 5554
  Complete submission text file 0001193125-18-325511.txt   3852877

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT avro-20180930.xml EX-101.INS 575184
6 XBRL TAXONOMY EXTENSION SCHEMA avro-20180930.xsd EX-101.SCH 51142
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avro-20180930_cal.xml EX-101.CAL 53988
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avro-20180930_def.xml EX-101.DEF 154236
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20180930_lab.xml EX-101.LAB 390822
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20180930_pre.xml EX-101.PRE 284386
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 181178258
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1